Tag: targeted therapy

Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study

Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…

ME Desk

Datroway: A Novel TROP2‑Directed Therapy Approved for Lung Cancer

AstraZeneca and Daiichi Sankyo’s new antibody drug conjugate, Datroway (datopotamab deruxtecan), has received accelerated…

ME Desk